Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Cancer
|
August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
Andrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Annals of Surgery
|
July 18, 2020
Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience
Ching-Wei D Tzeng, Mediget Teshome, Matthew H G Katz, et al.
Science Translational Medicine
|
August 15, 2014
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
Nicholas J Roberts, Linping Zhang, Filip Janku, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Bone & Joint Open
|
May 31, 2026
Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis
Maria A Smolle, Florian A Wenzl, Minna K Laitinen, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Cancer
|
August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
Andrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Annals of Surgery
|
July 18, 2020
Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience
Ching-Wei D Tzeng, Mediget Teshome, Matthew H G Katz, et al.
Science Translational Medicine
|
August 15, 2014
Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
Nicholas J Roberts, Linping Zhang, Filip Janku, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Bone & Joint Open
|
May 31, 2026
Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis
Maria A Smolle, Florian A Wenzl, Minna K Laitinen, et al.
Page
of 6